15-oxo-eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation

Molecular Pharmacology

Volumn 76, Issue 3, 2009, Pages 516-525

  Wei, Cong ^a   Zhu, Peijuan ^a   Shah, Sumit J ^a   Blair, Ian A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 OXO 5,8,11,13 ICOSATETRAENOIC ACID; ARACHIDONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG HALF LIFE; DRUG INHIBITION; DRUG METABOLISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACIDS; CELL LINE; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; MACROPHAGES; MICE; MONOCYTES;

EID: 69549138693     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.057489     Document Type: Article

References (45)

1. Backlund MG, Mann JR, Holla VR, Buchanan FG, Tai HH, Musiek ES, Milne GL, Katkuri S, and DuBois RN (2005) 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J Biol Chem 280:3217-3223. (Pubitemid 40223783)
2. Bergholte JM, Soberman RJ, Hayes R, Murphy RC, and Okita RT (1987) Oxidation of 15-hydroxyeicosatetraenoic acid and other hydroxy fatty acids by lung prostaglandin dehydrogenase. Arch Biochem Biophys 257:444-450.
3. Berry CN, Hoult JR, Peers SH, and Agback H (1983) Inhibition of prostaglandin 15-hydroxydehydrogenase by sulphasalazine and a novel series of potent analogues. Biochem Pharmacol 32:2863-2871.
4. Blair IA (2006) Endogenous glutathione adducts. Curr Drug Metab 7:853-872.
5. Blair IA (2008) DNA adducts with lipid peroxidation products. J Biol Chem 283:15545-15549.
6. Brinckmann R, Schnurr K, Heydeck D, Rosenbach T, Kolde G, and Kühn H (1998) Membrane translocation of 15-lipoxygenase in hematopoietic cells is calcium-dependent and activates the oxygenase activity of the enzyme. Blood 91:64-74. (Pubitemid 28018730)
7. Bryant RW, Bailey JM, Schewe T, and Rapoport SM (1982) Positional specificity of a reticulocyte lipoxygenase. Conversion of arachidonic acid to 15-S-hydroperoxyeicosatetraenoic acid. J Biol Chem 257:6050-6055.
8. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932-936.
9. 12,14-prostaglandin J2 inhibition of NF-κB-DNA binding through covalent modification of the P50 subunit. J Biol Chem 276:35530-35536.
10. Cha YI, Solnica-Krezel L, and DuBois RN (2006) Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins. Dev Biol 289:263-272. (Pubitemid 43049931)
11. Chaitidis P, Schewe T, Sutherland M, Kühn H, and Nigam S (1998) 15-Lipoxygenation of phospholipids may precede the Sn-2 cleavage by phospholipases A2: reaction specificities of secretory and cytosolic phospholipases a2 towards native and 15-lipoxygenated arachidonyl phospholipids. FEBS Lett 434:437-441. (Pubitemid 29052272)
12. Chatila TA (2004) Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med 10:493-499. (Pubitemid 39303622)
13. Cho H, Ueda M, Tamaoka M, Hamaguchi M, Aisaka K, Kiso Y, Inoue T, Ogino R, Tatsuoka T, and Ishihara T (1991) Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase. J Med Chem 34:1503-1505.
14. Fierro IM, Kutok JL, and Serhan CN (2002) Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4). J Pharmacol Exp Ther 300:385-392.
15. Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6:273-286. (Pubitemid 46505878)
16. González-Périz A and Clària J (2007) New approaches to the modulation of the cyclooxygenase-2 and 5-lipoxygenase pathways. Curr Top Med Chem 7:297-309. (Pubitemid 46358663)
17. Gulliksson M, Brunnström A, Johannesson M, Backman L, Nilsson G, Harvima I, Dahlén B, Kumlin M, and Claesson HE (2007) Expression of 15-lipoxygenase type-1 in human mast cells. Biochim Biophys Acta 1771:1156-1165. (Pubitemid 47404969)
18. Harats D, Ben-Shushan D, Cohen H, Gonen A, Barshack I, Goldberg I, Greenberger S, Hodish I, Harari A, Varda-Bloom N, et al. (2005) Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter. Cancer Lett 229:127-134. (Pubitemid 41262549)
19. Huo Y, Zhao L, Hyman MC, Shashkin P, Harry BL, Burcin T, Forlow SB, Stark MA, Smith DF, Clarke S, et al. (2004) Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation 110:2024-2031. (Pubitemid 39331917)
20. Jian W, Lee SH, Williams MV, and Blair IA (2009) 5-Lipoxygenase-mediated endogenous DNA damage. J Biol Chem 284:16799-16807.
21. Kühn H and Borchert A (2002) Regulation of enzymatic lipid peroxidation: the interplay of peroxidizing and peroxide reducing enzymes. Free Radic Biol Med 33:154-172. (Pubitemid 34775188)
22. Kühn H and Chan L (1997) The role of 15-lipoxygenase in atherogenesis: pro- and antiatherogenic actions. Curr Opin Lipidol 8:111-117. (Pubitemid 27235071)
23. Kühn H and O'Donnell VB (2006) Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 45:334-356.
24. Lee SH and Blair IA (2007) Targeted chiral lipidomics analysis by liquid chromatography electron capture atmospheric pressure chemical ionization mass spectrometry (LC-ECAPCI/MS). Methods Enzymol 433:159-174.
25. Lee SH, Rangiah K, Williams MV, Wehr AY, DuBois RN, and Blair IA (2007) Cyclooxygenase-2-mediated metabolism of arachidonic acid to 15-oxo- eicosatetraenoic acid by rat intestinal epithelial cells. Chem Res Toxicol 20:1665-1675. (Pubitemid 350275612)
26. Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, Valledor AF, Davis RA, Willson TM, Witztum JL, et al. (2004) Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest 114:1564-1576. (Pubitemid 40385547)
27. Maskrey BH, Bermúdez-Fajardo A, Morgan AH, Stewart-Jones E, Dioszeghy V, Taylor GW, Baker PR, Coles B, Coffey MJ, Kühn H, et al. (2007) Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase. J Biol Chem 282:20151-20163. (Pubitemid 47100012)
28. Merched AJ, Ko K, Gotlinger KH, Serhan CN, and Chan L (2008) Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 22:3595-3606.
29. Mesaros C, Lee SH, and Blair IA (2009) Targeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci doi: 10.1016/j.jchromb.2009.03.011.
30. Middleton MK, Zukas AM, Rubinstein T, Jacob M, Zhu P, Zhao L, Blair I, and Puré E (2006) Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease. J Exp Med 203:2529-2540. (Pubitemid 44664622)
31. Murphy RC and Zarini S (2002) Glutathione adducts of oxyeicosanoids. Prostaglandins Other Lipid Mediat 68-69:471-482.
32. O'Flaherty JT, Rogers LC, Paumi CM, Hantgan RR, Thomas LR, Clay CE, High K, Chen YQ, Willingham MC, Smitherman PK, et al. (2005) 5-Oxo-ETE analogs and the proliferation of cancer cells. Biochim Biophys Acta 1736:228-236. (Pubitemid 41423707)
33. Porter NA, Caldwell SE, and Mills KA (1995) Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30:277-290.
34. Powell WS and Rokach J (2005) Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE. Prog Lipid Res 44:154-183.
35. Quidville V, Segond N, Lausson S, Frenkian M, Cohen R, and Jullienne A (2006) 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line. Prostaglandins Other Lipid Mediat 81:14-30. (Pubitemid 44403167)
36. Salomon RG, Kaur K, Podrez E, Hoff HF, Krushinsky AV, and Sayre LM (2000) HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques. Chem Res Toxicol 13:557-564. (Pubitemid 30491116)
37. Schnurr K, Brinckmann R, and Kühn H (1999) Cytokine induced regulation of 15-lipoxygenase and phospholipid hydroperoxide glutathione peroxidase in mammalian cells. Adv Exp Med Biol 469:75-81. (Pubitemid 32204618)
38. Serhan CN, Chiang N, and Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349-361. (Pubitemid 351595216)
39. Sozzani S, Zhou D, Locati M, Bernasconi S, Luini W, Mantovani A, and O'Flaherty JT (1996) Stimulating properties of 5-oxo-eicosanoids for human monocytes: synergism with monocyte chemotactic protein-1 and -3. J Immunol 157:4664-4671. (Pubitemid 126449390)
40. Tai HH, Tong M, and Ding Y (2007) 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer. Prostaglandins Other Lipid Mediat 83:203-208. (Pubitemid 46661259)
41. Viita H, Markkanen J, Eriksson E, Nurminen M, Kinnunen K, Babu M, Heikura T, Turpeinen S, Laidinen S, Takalo T, et al. (2008) 15-Lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression. Circ Res 102:177-184.
42. Walther M, Wiesner R, and Kuhn H (2004) Investigations into calcium-dependent membrane association of 15-lipoxygenase-1. Mechanistic roles of surface-exposed hydrophobic amino acids and calcium. J Biol Chem 279:3717-3725. (Pubitemid 38140615)
43. Weibel GL, Joshi MR, Alexander ET, Zhu P, Blair IA, and Rothblat GH (2009) Overexpression of human 15(S)-lipoxygenase-1 in RAW macrophages leads to increased cholesterol mobilization and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 29:837-842.
44. Wittwer J and Hersberger M (2007) The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 77:67-77.
45. Zhu P, Oe T, and Blair IA (2008) Determination of cellular redox status by stable isotope dilution liquid chromatography/mass spectrometry analysis of glutathione and glutathione disulfide. Rapid Commun Mass Spectrom 22:432-440. (Pubitemid 351300575)